Skip to main content
. Author manuscript; available in PMC: 2020 May 23.
Published in final edited form as: J Med Chem. 2018 Dec 27;62(10):4851–4883. doi: 10.1021/acs.jmedchem.8b00843

Figure 1.

Figure 1.

A) The overall architecture of HIV-1 is shown and B) Three-dimensional structure of HIV-1 RT (p66/p51) in complex with nucleic acids is highlighted in different colors. C) A brief timeline of HIV-1 drug development and in particular the drugs identified for RT are highlighted. The two-dimensional (2D) representation of approved NNRTI drugs is depicted.